Propolis shows antimicrobial activity but suffers from poor solubility, and stability. • Key gut pathogens (H. pylori, F. nucleatum, C. difficile) worsen GI disorders. • Increasing antimicrobial resistance underscores the need for alternative therapeutic approaches. • SLNs represent a promising strategy to improve propolis delivery and therapeutic potential in GI conditions.
Propolis-loaded solid lipid nanoparticles targeting H. pylori associated with gastro-intestinal diseases
Robuffo, Iole;
2026
Abstract
Propolis shows antimicrobial activity but suffers from poor solubility, and stability. • Key gut pathogens (H. pylori, F. nucleatum, C. difficile) worsen GI disorders. • Increasing antimicrobial resistance underscores the need for alternative therapeutic approaches. • SLNs represent a promising strategy to improve propolis delivery and therapeutic potential in GI conditions.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2026_JFunctional Foods-1-s2.0-S1756464626002227-main.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Altro tipo di licenza
Dimensione
3.78 MB
Formato
Adobe PDF
|
3.78 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
